British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

被引:221
作者
Chapman, Michael Huw [1 ,2 ]
Thorburn, Douglas [2 ]
Hirschfield, Gideon M. [3 ,4 ]
Webster, George G. J. [1 ]
Rushbrook, Simon M. [5 ]
Alexander, Graeme [2 ]
Collier, Jane [6 ]
Dyson, Jessica K. [7 ,8 ]
Jones, David E. J. [8 ]
Patanwala, Imran [9 ,10 ]
Thain, Collette [11 ]
Walmsley, Martine [12 ]
Pereira, Stephen P. [1 ,13 ]
机构
[1] UCL Hosp NHS Fdn Trust, GI Div, London, England
[2] Royal Free London NHS Fdn Trust, Liver Unit, London, England
[3] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Norfolk & Norwich Univ Hosp NHS Trust, Dept Hepatol, Norwich, Norfolk, England
[6] John Radcliffe Hosp, Hepatol, Oxford, England
[7] Newcastle Tyne Hosp NHS Fdn Trust, Hepatol, Newcastle Upon Tyne, Tyne & Wear, England
[8] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
[9] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Gastroenterol, Liverpool, Merseyside, England
[10] Univ Liverpool, Liverpool, Merseyside, England
[11] PBC Fdn, Edinburgh, Midlothian, Scotland
[12] Chair Trustees PSC Support, Didcot, Oxon, England
[13] UCL, Inst Liver & Digest Hlth, London, England
关键词
INFLAMMATORY-BOWEL-DISEASE; DOSE URSODEOXYCHOLIC ACID; PRIMARY BILIARY-CIRRHOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOGRAPHY; IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; ORTHOTOPIC LIVER-TRANSPLANTATION; POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; IN-SITU HYBRIDIZATION;
D O I
10.1136/gutjnl-2018-317993
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
These guidelines on the management of primary sclerosing cholangitis (PSC) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included medical representatives from hepatology and gastroenterology groups as well as patient representatives from PSC Support. The guidelines aim to support general physicians, gastroenterologists and surgeons in managing adults with PSC or those presenting with similar cholangiopathies which may mimic PSC, such as IgG4 sclerosing cholangitis. It also acts as a reference for patients with PSC to help them understand their own management. Quality of evidence is presented using the AGREE II format. Guidance is meant to be used as a reference rather than for rigid protocol-based care as we understand that management of patients often requires individual patient-centred considerations.
引用
收藏
页码:1356 / 1378
页数:23
相关论文
共 275 条
[1]
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline [J].
Aabakken, Lars ;
Karlsen, Tomh. ;
Albert, Joerg ;
Arvanitakis, Marianna ;
Chazouilleres, Olivier ;
Dumonceau, Jean-Marc ;
Farkkila, Martti ;
Fickert, Peter ;
Hirschfield, Gideon M. ;
Laghi, Andrea ;
Marzioni, Marco ;
Fernandez, Michael ;
Pereira, Stephen P. ;
Pohl, Juergen ;
Poley, Jan-Werner ;
Ponsioen, Cyriel Y. ;
Schramm, Christoph ;
Swahn, Fredrik ;
Tringali, Andrea ;
Hassan, Cesare .
ENDOSCOPY, 2017, 49 (06) :588-608
[2]
Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome [J].
Abdo, AA ;
Bain, VG ;
Kichian, K ;
Lee, SS .
HEPATOLOGY, 2002, 36 (06) :1393-1399
[3]
Primary sclerosing cholangitis - Resect, dilate, or transplant? [J].
Ahrendt, SA ;
Pitt, HA ;
Kalloo, AN ;
Venbrux, AC ;
Klein, AS ;
Herlong, HF ;
Coleman, J ;
Lillemoe, KD ;
Cameron, JL .
ANNALS OF SURGERY, 1998, 227 (03) :412-423
[4]
Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis [J].
Ahrendt, SA ;
Pitt, HA ;
Nakeeb, A ;
Klein, AS ;
Lillemoe, KD ;
Kalloo, AN ;
Cameron, JL .
JOURNAL OF GASTROINTESTINAL SURGERY, 1999, 3 (04) :357-367
[5]
Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis [J].
Al Mamari, Said ;
Djordjevic, Jelena ;
Halliday, John S. ;
Chapman, Roger W. .
JOURNAL OF HEPATOLOGY, 2013, 58 (02) :329-334
[6]
Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival [J].
Al-Chalabi, T. ;
Portmann, B. C. ;
Bernal, W. ;
Mcfarlane, I. G. ;
Heneghan, M. A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (02) :209-220
[7]
A Re-Evaluation of the Risk Factors for the Recurrence of Primary Sclerosing Cholangitis in Liver Allografts [J].
Alabraba, Edward ;
Nightingale, Peter ;
Gunson, Bridget ;
Hubscher, Stefan ;
Olliff, Simon ;
Mirza, Darius ;
Neuberger, James .
LIVER TRANSPLANTATION, 2009, 15 (03) :330-340
[8]
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence [J].
Alberts, DS ;
Martínez, ME ;
Hess, LM ;
Einspahr, JG ;
Green, SB ;
Bhattacharyya, AK ;
Guillen, J ;
Krutzsch, M ;
Batta, AK ;
Salen, G ;
Fales, L ;
Koonce, K ;
Parish, D ;
Clouser, M ;
Roe, D ;
Lance, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (11) :846-853
[9]
Current research on the treatment of primary sclerosing cholangitis [J].
Ali, Ahmad H. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
INTRACTABLE & RARE DISEASES RESEARCH, 2015, 4 (01) :1-6
[10]
Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis [J].
Ali, Ahmad Hassan ;
Tabibian, James H. ;
Nasser-Ghodsi, Navine ;
Lennon, Ryan J. ;
DeLeon, Thomas ;
Borad, Mitesh J. ;
Hilscher, Moira ;
Silveira, Marina G. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
HEPATOLOGY, 2018, 67 (06) :2338-2351